1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

A-team

Discussion in 'Celgene' started by anonymous, Sep 5, 2019 at 2:35 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I was very impressed with today’s meeting. Really appreciated the transparency and was shocked to hear the commitment to no layoffs. Anyone else feel positive after that call?

    Where in NJ do you think they’ll put the office?
     
  2. anonymous

    anonymous Guest

    Top choices:
    Camden
    East Orange
    Pine Hill
    Plainfield
    Millville
    Lindenwold
     
  3. anonymous

    anonymous Guest

    Yes, call was great. I give it 3-6 months before complete overhaul with immunology division. THEN the lay-offs begin!
     
  4. anonymous

    anonymous Guest


    Wrong numb nuts. We bought Onyx and it took us 30 months before we did anything with them. Our model is to bolt them on, study them, slowly kill off their leadership, and then absorb the drones once they've acclimated to our activity heavy culture.

    I give it 3-6 minutes before you make another imbecilic comment.
     
  5. anonymous

    anonymous Guest


    Sounds lovely....... now go back to your own board Amgen troll
     
  6. anonymous

    anonymous Guest

    The Onyx buyout was over five years ago. But keep drinking that kool aid
     
  7. anonymous

    anonymous Guest


    Loved the candor between Celgene and Amgen and the overall positivity. Looking forward to the close and soooo happy we’re not stuck with BMS
     
  8. anonymous

    anonymous Guest

    BMS sucks